Hepatitis B Immune Globulin (HBIg) to Restore Immune Control in People With Chronic Hepatitis B
Clinical trial NCT03575208 · WITHDRAWN
Trial details
- NCT number
- NCT03575208
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-13
- Primary completion
- 2022-03-29
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.